A Study to Assess Bioequivalence of Fezolinetant Formulations in Healthy Female Participants
Clinical trial NCT04277624 · COMPLETED
Trial details
- NCT number
- NCT04277624
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2021-02-21
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.